Dogwood Therapeutics, INC. (DWTX) SEC Filings — 2025

Filings

• Dogwood Therapeutics, INC. 8-K Filing — 8-K · Nov 28, 2025
• Dogwood Therapeutics, INC. 8-K Filing — 8-K · Nov 21, 2025
• Dogwood Therapeutics' Losses Soar Amid R&D Surge, Going Concern Doubt Looms — 10-Q · Nov 7, 2025
• Dogwood Therapeutics, INC. 8-K Filing — 8-K · Nov 6, 2025
• DWTX Seeks Shareholder Nod for Preferred Stock Conversion, Equity Plan — DEF 14A · Oct 20, 2025
• Dogwood Therapeutics Files DEFA14A — DEFA14A · Oct 9, 2025
• Dogwood Therapeutics Files 8-K on Key Corporate Events — 8-K · Sep 29, 2025
• Dogwood's Losses Soar Amid R&D Surge, Going Concern Doubts Emerge — 10-Q · Aug 13, 2025
• Dogwood Therapeutics Announces Director and Officer Changes — 8-K · Jul 2, 2025
• Dogwood Therapeutics Files 8-K: Board & Compensation Updates — 8-K · Jun 24, 2025
• Dogwood Therapeutics Files Q1 2025 10-Q — 10-Q · May 9, 2025
• Dogwood Therapeutics Files 8-K on Financials — 8-K · May 8, 2025
• Dogwood Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 30, 2025
• Dogwood Therapeutics Files 8-K with Exhibits — 8-K · Apr 3, 2025
• Dogwood Therapeutics Files 2024 10-K — 10-K · Mar 31, 2025
• Dogwood Therapeutics Enters Material Definitive Agreement — 8-K · Mar 14, 2025
• Dogwood Therapeutics Files 8-K with Key Corporate Updates — 8-K · Mar 12, 2025